JCI - The genesis of cystic fibrosis lung disease

The genesis of cystic fibrosis lung disease

Jeffrey J. Wine

Published in Volume 103, Issue 3

J Clin Invest. 1999; 103(3):309 doi:10.1172/JCI6222

Full text | PDF

Citation information

Citation in:
Citations:

2011
3

2010
4

2009
2

2008
1

2007
2

2003
1

2002
3

2001
3

2000
7

Total
10

Title and authors	Publication	Year	.
Role of CFTR expressed by neutrophils in modulating acute lung inflammation and injury in mice Xiao Su, Mark R. Looney, Hang (Emily) Su, Jae Woo Lee, Yuanlin Song, Michael A. Matthay	Inflamm res	2011	.
Nano-based theranostics for chronic obstructive lung diseases: challenges and therapeutic potential Neeraj Vij	Expert Opin Drug Deliv	2011	.
Human cystic fibrosis airway epithelia have reduced Cl- conductance but not increased Na+ conductance O. A. Itani, J.-H. Chen, P. H. Karp, S. Ernst, S. Keshavjee, K. Parekh, J. Klesney-Tait, J. Zabner, M. J. Welsh	proc natn acad sci usa	2011	.
Cystic fibrosis lung disease starts in the small airways: Can we treat it more effectively? Harm A.W.M. Tiddens, Scott H. Donaldson, Margaret Rosenfeld, Peter D. Paré	Pediat Pulmonol	2010	.
Role of Alveolar Macrophages in Productions of Prostaglandin D2and E2in the Inflamed Lung	Journal of Life Science	2010	.
Diagnosing Cystic Fibrosis at All Ages Maggie Sifain, Clement L. Ren	Clinical Pulmonary Medicine	2010	.
Prostaglandin-endoperoxide synthase genesCOX1 andCOX2 — novel modifiers of disease severity in cystic fibrosis patients K. Czerska, A. Sobczyńska-Tomaszewska, D. Sands, A. Nowakowska, D. Bąk, K. Wertheim, J. Poznański, J. Zielenski, A. Norek, J. Bal	J Appl Genet	2010	.
Pseudomonas aeruginosa virulence and therapy: Evolving translational strategies* Jeffrey L. Veesenmeyer, Alan R. Hauser, Thiago Lisboa, Jordi Rello	Crit Care Med	2009	.
Innate immune receptors on neutrophils and their role in chronic lung disease B. Koller, R. Bals, D. Roos, H. C. Korting, M. Griese, D. Hartl	Eur J Clin Invest	2009	.
Diagnosis of Cystic Fibrosis Karen Z. Voter, Clement L. Ren	CRIAI	2008	.
Mucociliary clearance – a critical upper airway host defense mechanism and methods of assessment Marcelo B Antunes, Noam A Cohen	Curr Opin Allergy Clin Immunol	2007	.
Evidence for airway surface dehydration as the initiating event in CF airway disease R. C. Boucher	j int med	2007	.
Selective toxicity of engineered lentivirus lytic peptides in a CF airway cell model Shruti M. Phadke, Kazi Islam, Berthony Deslouches, Sunil A. Kapoor, Donna Beer Stolz, Simon C. Watkins, Ronald C. Montelaro, Joseph M. Pilewski, Timothy A. Mietzner	Peptides (Fayetteville)	2003	.
Rescuing protein conformation: prospects for pharmacological therapy in cystic fibrosis Marina S. Gelman, Ron R. Kopito	J Clinic Invest	2002	.
Mucus clearance as a primary innate defense mechanism for mammalian airways Michael R. Knowles, Richard C. Boucher	J Clinic Invest	2002	.
Airway mucus in cystic fibrosis Edith Puchelle, Odile Bajolet, Michel Abély	Paed Resp Rev	2002	.
Noninvasive in vivo fluorescence measurement of airway-surface liquid depth, salt concentration, and pH Sujatha Jayaraman, Yuanlin Song, L. Vetrivel, Leena Shankar, A.S. Verkman	J Clinic Invest	2001	.
ISOLATION AND CULTURE OF AIRWAY EPITHELIAL CELLS FROM CHRONICALLY INFECTED HUMAN LUNGS SCOTT H. RANDELL, DIANA L. WALSTAD, UTE E. SCHWAB, BARBARA R. GRUBB, JAMES R. YANKASKAS	In Vitro Cell Dev Biol Anim	2001	.
Gene therapy for cystic fibrosis A Christopher Boyd	eotp	2001	.
Modifier Genes Convert “Simple” Mendelian Disorders to Complex Traits Katrina M. Dipple, Edward R.B. McCabe	Mol Genet Metab	2000	.

« Previous 1 2 Next »